{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-107906","form_type":"8-K","ticker":"TARA","cik":"0001359931","company_name":"Protara Therapeutics, Inc.","filed_at":"2024-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.253207+00:00","generated_at":"2026-05-29T04:39:52.192532+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Protara Therapeutics raises $100M in public offering to fund TARA-002 clinical development","bullets":["Gross proceeds of ~$100M from offering of 13.69M shares and 2.33M pre-funded warrants at $6.25/share.","Proceeds to fund clinical development of TARA-002 for cancer and rare diseases; also working capital.","Underwriters granted 30-day option to purchase up to 2.4M additional shares; company and insiders have 60-day lock-up.","Offering closed December 11, 2024; TD Cowen, Cantor, LifeSci Capital, Oppenheimer & Co., Scotiabank acted as joint book-runners.","Pre-funded warrants exercisable at $0.001, with ownership limitation of 4.99% (adjustable to 19.99%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-107906","json":"https://secwatch.observer/filing/0001213900-24-107906.json","markdown":"https://secwatch.observer/filing/0001213900-24-107906.md","text":"https://secwatch.observer/filing/0001213900-24-107906.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024107906/0001213900-24-107906-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024107906/ea0224389-8k_protara.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:39:52.192532+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}